Autolus Therapeutics plc (AUTL)

NASDAQ: AUTL · Real-Time Price · USD

1.370

-0.060 (-4.20%)

At close: Mar 20, 2026, 4:00 PM EDT

1.380

+0.010 (0.73%)

After-hours: Mar 20, 2026, 7:57 PM EDT

Autolus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	365	625	1,120	329	378	468
Market Cap Growth	-33.81%	-44.17%	240.67%	-13.12%	-19.06%	-21.26%
Enterprise Value	322	269	1,057	233	227	343
Last Close Price	1.37	2.35	6.44	1.90	5.19	8.94
PS Ratio	7.13	61.80	659.69	51.70	162.43	272.63
PB Ratio	1.37	1.46	10.05	1.10	1.21	2.23
P/TBV Ratio	1.49	1.51	10.05	1.10	1.21	2.23
EV/Sales Ratio	6.31	26.63	622.48	36.69	97.51	199.84
Debt / Equity Ratio	1.23	0.70	2.01	0.50	0.22	0.26
Net Debt / Equity Ratio	-0.16	-0.68	-0.14	-0.78	-0.77	-0.47
Net Debt / EBITDA Ratio	0.16	1.25	0.09	1.71	1.84	0.61
Net Debt / FCF Ratio	0.15	1.27	0.10	1.89	1.91	0.75
Asset Turnover	0.07	0.02	0.00	0.01	0.01	0.01
Quick Ratio	5.52	10.48	5.90	8.87	11.79	5.44
Current Ratio	6.19	10.88	6.15	9.18	12.15	5.86
Return on Equity (ROE)	-60.56%	-81.91%	-101.61%	-48.64%	-54.30%	-61.13%
Return on Assets (ROA)	-22.99%	-25.99%	-25.35%	-19.94%	-25.07%	-35.16%
Return on Capital Employed (ROCE)	-47.30%	-33.40%	-53.10%	-32.20%	-37.20%	-64.50%
Earnings Yield	-61.65%	-35.28%	-18.60%	-45.27%	-37.55%	-30.39%
FCF Yield	-78.22%	-36.51%	-13.98%	-37.45%	-33.48%	-28.33%
Buyback Yield / Dilution	-14.65%	-46.69%	-83.11%	-31.78%	-39.81%	-19.72%

Updated Nov 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q